Samuel C. Blackman

Directeur Médical

Insider activity · 24 months0 buys1 saleCumulative net flow

Dec 24 · 0 buys · 1 saleJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (44 ops.)

€6.2M

Latest filing published 12 Dec 2024 for Day One Biopharmaceuticals, Inc., €378k.

Filing timeline

BuySale

Samuel C. Blackman

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Samuel C. Blackman: trading record in brief

Samuel C. Blackman is a declared insider of Day One Biopharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 22 October 2021 to 10 December 2024, the count stands at 68 filings.

The open-market record consists of 44 sales worth €6.2M, with no purchase. Besides market trades, the filings include 22 option exercises. Since January 2024: no purchases and 17 sales on the market.

Most recently, on 12 December 2024, the filings show an open-market sale worth €378k in Day One Biopharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Samuel C. Blackman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Day One Biopharmaceuticals, Inc. (US)

Declarations35 total

▼
Samuel C. Blackman
HEAD OF R&DExecutives10 Dec 2024Day One Biopharmaceuticals, Inc.
399,339 USD15SEC
30,000 shares@ US$13.31136.8% of flowCommon StockSEC:0001415889-24-029085:0
◇
Samuel C. Blackman
HEAD OF R&DExecutives15 Nov 2024Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001415889-24-027234:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives8 Nov 2024Day One Biopharmaceuticals, Inc.
295,229 USD14SEC
18,255 shares@ US$16.17254.9% of flowCommon StockSEC:0001415889-24-026624:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives7 Nov 2024Day One Biopharmaceuticals, Inc.
180,287 USD14SEC
11,245 shares@ US$16.03263.0% of flowCommon StockSEC:0001415889-24-026434:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives31 Oct 2024Day One Biopharmaceuticals, Inc.
8,010 USD14SEC
500 shares@ US$16.020.1% of flowCommon StockSEC:0001415889-24-026036:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives10 Sept 2024Day One Biopharmaceuticals, Inc.
426,675 USD15SEC
30,000 shares@ US$14.22256.9% of flowCommon StockSEC:0001415889-24-023298:0
◇
Samuel C. Blackman
HEAD OF R&DExecutives15 Aug 2024Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001415889-24-021621:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives16 Jul 2024Day One Biopharmaceuticals, Inc.
320,226 USD27SEC
20,000 shares@ US$16.01135.3% of flowCommon StockSEC:0001415889-24-019681:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives10 Jun 2024Day One Biopharmaceuticals, Inc.
378,588 USD27SEC
30,000 shares@ US$12.61966.3% of flowCommon StockSEC:0001415889-24-016507:0
◇
Samuel C. Blackman
HEAD OF R&DExecutives15 May 2024Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001415889-24-013618:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives10 May 2024Day One Biopharmaceuticals, Inc.
163,743 USD29SEC
10,000 shares@ US$16.37432.7% of flowCommon StockSEC:0001415889-24-013159:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives18 Apr 2024Day One Biopharmaceuticals, Inc.
160,163 USD29SEC
10,000 shares@ US$16.01632.7% of flowCommon StockSEC:0001415889-24-011332:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives25 Mar 2024Day One Biopharmaceuticals, Inc.
160,055 USD14SEC
10,000 shares@ US$16.00552.6% of flowCommon StockSEC:0001415889-24-009146:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives11 Mar 2024Day One Biopharmaceuticals, Inc.
457,314 USD15SEC
30,000 shares@ US$15.24387.5% of flowCommon StockSEC:0001415889-24-007810:0
▼
Samuel C. Blackman
HEAD OF R&DExecutives27 Feb 2024Day One Biopharmaceuticals, Inc.
322,166 USD15SEC
20,000 shares@ US$16.10835.3% of flowCommon StockSEC:0001415889-24-005787:0
◇
Samuel C. Blackman
HEAD OF RESEARCH AND DEVELOPMEExecutives15 Feb 2024Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001415889-24-004459:0
◇
Samuel C. Blackman
Head of Research and DevelopmeExecutives15 Nov 2023Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001209191-23-055884:0
◇
Samuel C. Blackman
Head of Research and DevelopmeExecutives15 Aug 2023Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001209191-23-046418:0
▼
Samuel C. Blackman
Chief Medical OfficerExecutives5 Jun 2023Day One Biopharmaceuticals, Inc.
19,664 USD14SEC
1,229 shares@ US$16.000.3% of flowCommon StockSEC:0001209191-23-035128:0
◇
Samuel C. Blackman
Chief Medical OfficerExecutives15 May 2023Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001209191-23-030392:0
▼
Samuel C. Blackman
Chief Medical OfficerExecutives10 Mar 2023Day One Biopharmaceuticals, Inc.
180,484 USD32SEC
10,000 shares@ US$18.04843.1% of flowCommon StockSEC:0001209191-23-018617:0
◇
Samuel C. Blackman
Chief Medical OfficerExecutives15 Feb 2023Day One Biopharmaceuticals, Inc.
0SEC
1,187 sharesCommon StockSEC:0001209191-23-010812:0
▼
Samuel C. Blackman
Chief Medical OfficerExecutives10 Feb 2023Day One Biopharmaceuticals, Inc.
200,659 USD32SEC
10,000 shares@ US$20.06593.3% of flowCommon StockSEC:0001209191-23-008862:0
▼
Samuel C. Blackman
Chief Medical OfficerExecutives10 Jan 2023Day One Biopharmaceuticals, Inc.
170,633 USD32SEC
7,500 shares@ US$22.7512.8% of flowCommon StockSEC:0001209191-23-003020:0
▼
Samuel C. Blackman
Chief Medical OfficerExecutives1 Dec 2022Day One Biopharmaceuticals, Inc.
194,590 USD32SEC
9,100 shares@ US$21.38353.3% of flowCommon StockSEC:0001209191-22-059716:0

25 of 35 declarations

Samuel C. Blackman

Insider track record

Samuel C. Blackman: trading record in brief

Companies and markets linked to Samuel C. Blackman

Similar companies

Related executives